Health Care & Life Sciences » Biotechnology | Infinity Pharmaceuticals Inc.

Infinity Pharmaceuticals Inc. | Ownership

Companies that own Infinity Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BVF Partners LP
15,232,268
26.79%
5,465,760
2.31%
06/30/2018
The Vanguard Group, Inc.
2,166,697
3.81%
194,417
0%
06/30/2018
Wellington Management Co. LLP
1,598,309
2.81%
88,000
0%
06/30/2018
Platinum Investment Management Ltd.
1,130,432
1.99%
-168,800
0.03%
06/30/2018
BlackRock Fund Advisors
964,016
1.7%
19,473
0%
06/30/2018
Dimensional Fund Advisors LP
932,370
1.64%
198,098
0%
06/30/2018
Baker Bros. Advisors LP
580,400
1.02%
0
0.01%
06/30/2018
Renaissance Technologies LLC
542,700
0.96%
-24,800
0%
06/30/2018
First Eagle Investment Management LLC
500,000
0.88%
500,000
0%
06/30/2018
Bridgeway Capital Management, Inc.
459,000
0.81%
0
0.01%
06/30/2018

About Infinity Pharmaceuticals

View Profile
Address
784 Memorial Drive
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.infi.com
Updated 07/08/2019
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.